Synthetic peptide: C-GLNVGNFTGAKQASSQ, with N-terminally added cysteine, conjugated to maleimide activated KLH, corresponding to amino acids 653-668 of Human FOXO3A.
Our Abpromise guarantee covers the use of ab12162 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||Use at an assay dependent concentration.|
|WB||1/2500. Detects a band of approximately 70-75 kDa (predicted molecular weight: 71 kDa). In some preparations there is an additional band at 35 kDa.
A customer reported the antibody did not detect endogenous FOX03A in human cancer cells (see enquiries).
|ICC/IF||Use at an assay dependent concentration.|
|ChIP||Use at an assay dependent concentration.|
Pig coronary artery endothelial cells were cross-linked for 10 minutes at room temperature by adding 37% formaldehyde to the culture medium. The fixed cells were lysed and the chromatin was isolated. For ChIP, sheared chromatin was incubated with Anti-FOXO3A antibody - ChIP Grade (ab12162). The cells were incubated with wortmannin (30 nM), SB 203580 (10 µM) and SP 600125 (30 µM) for 30 minutes before the addition of CGJ for 30 minutes. n = 4 different experiments. *P<0.05 versus control, #P<0.05 versus CGJ treatment. Endothelial cells were exposed to CGJ for 30 minutes and then chromatin-bound DNA was immunoprecipitated with an antibody against FoxO3a.
ab12162 staining FOXO3A in Rat fibroblast cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with paraformaldehyde, permeabilized with 0.03% Triton X-100 and blocked with 5% serum for 10 minutes at 25°C. Samples were incubated with primary antibody (1/300) for 1 hour at 25°C.
This image is courtesy of an anonymous abreview.
Image from Åhsberg J et al, J Biol Chem. 2010 Nov 19;285(47):36275-84. Epub 2010 Sep 9, Fig 7. DOI 10.1074/jbc.M110.155531 November 19, 2010 Journal of Biological Chemistry, 285, 36275-36284.For protein extraction, murine BaF3Flt-3,Il-7 cells were washed in ice-cold PBS and immediately resuspended in lysis buffer containing 25 mm Tris (pH 7.5), 1% Triton X-100, 150 mm NaCl, 1 mm DTT, 1 mm EDTA (pH 8.0), 1× protease inhibitor mixture and 1 mm Na3VO4. Samples were centrifuged 1000 × g for 2 minutes and supernatant was mixed with 1× LDS sample buffer and 0.01 m DTT. Samples were heated at 70 °C for 10 minutes before separated by SDS-PAGE and blotted onto a PVDF transfer membrane. Membranes were blocked in 5% milk PBS/Tween or 5% BSA TBS/Tween for 1 hour at room temperature and next incubated with primary antibodies for 1 hour at room temperature or at 8 °C overnight. Following block, membranes were incubated with HRP-conjugated secondary antibody for 1 hour at room temperature. Blots were developed by enhanced chemiluminescence.
ab12162 staining FOXO3A in human brain tissue sections by Immunohistochemistry (PFA perfusion fixed frozen sections). Tissue samples were fixed by perfusion with formaldehyde, permeablized with 0.01% Triton-X 100 and blocked with 5% serum for 4 hours at 25°C. The sample was incubated with primary antibody (1/300) at 4°C for 10 hours. An Alexa Fluor® 594-conjugated donkey anti-rabbit IgG polyclonal (1/300) was used as the secondary antibody.